XML 72 R36.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Consolidated Supplementary Insurance Information | 12 Months Ended
--- | ---
Dec. 31, 2024
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract] |
Consolidated Supplementary Insurance Information | MetLife, Inc. Schedule III Consolidated Supplementary Insurance Information December 31, 2024 and 2023 (In millions)
|  | DAC and VOBA |  | FPBs, Other Policy-Related Balances and Policyholder Dividend Obligation |  | PABs |  | MRB (Assets) Liabilities (1) |  | Policyholder Dividends Payable |  | Unearned Premiums (2), (3) |  | UREV (2)
2024 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Group Benefits |  | $ | 250 |  |  | $ | 18,219 |  |  | $ | 7,632 |  |  | $ | — |  |  | $ | — |  |  | $ | 593 |  |  | $ | — |
RIS |  | 565 |  |  | 73,356 |  |  | 84,923 |  |  | 2 |  |  | — |  |  | — |  |  | 27 |
Asia |  | 11,720 |  |  | 32,294 |  |  | 94,903 |  |  | 215 |  |  | 81 |  |  | 1,175 |  |  | 3,076 |
Latin America |  | 2,229 |  |  | 14,094 |  |  | 5,514 |  |  | — |  |  | — |  |  | 2 |  |  | 841 |
EMEA |  | 1,758 |  |  | 3,419 |  |  | 7,214 |  |  | (81) |  |  | — |  |  | 22 |  |  | 622 |
MetLife Holdings |  | 3,077 |  |  | 70,441 |  |  | 21,274 |  |  | 2,069 |  |  | 304 |  |  | 155 |  |  | 69 |
Corporate & Other |  | 28 |  |  | 722 |  |  | (15) |  |  | 4 |  |  | — |  |  | — |  |  | — |
Total |  | $ | 19,627 |  |  | $ | 212,545 |  |  | $ | 221,445 |  |  | $ | 2,209 |  |  | $ | 385 |  |  | $ | 1,947 |  |  | $ | 4,635 |
2023 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Group Benefits |  | $ | 258 |  |  | $ | 17,863 |  |  | $ | 7,692 |  |  | $ | — |  |  | $ | — |  |  | $ | 446 |  |  | $ | — |
RIS |  | 413 |  |  | 71,223 |  |  | 82,405 |  |  | (13) |  |  | — |  |  | 7 |  |  | 31 |
Asia |  | 11,983 |  |  | 35,683 |  |  | 92,063 |  |  | 234 |  |  | 75 |  |  | 1,532 |  |  | 2,850 |
Latin America |  | 2,447 |  |  | 14,636 |  |  | 6,368 |  |  | — |  |  | — |  |  | 2 |  |  | 989 |
EMEA |  | 1,731 |  |  | 3,463 |  |  | 7,578 |  |  | (53) |  |  | — |  |  | 18 |  |  | 608 |
MetLife Holdings |  | 3,289 |  |  | 72,410 |  |  | 23,178 |  |  | 2,722 |  |  | 311 |  |  | 155 |  |  | 59 |
Corporate & Other |  | 30 |  |  | 864 |  |  | (15) |  |  | 3 |  |  | — |  |  | — |  |  | — |
Total |  | $ | 20,151 |  |  | $ | 216,142 |  |  | $ | 219,269 |  |  | $ | 2,893 |  |  | $ | 386 |  |  | $ | 2,160 |  |  | $ | 4,537 |
__________________ (1)MRB assets and liabilities are presented net. (2)Amounts are included within the FPBs, other policy-related balances and policyholder dividend obligation column. (3)Includes premiums received in advance. MetLife, Inc. Schedule III Consolidated Supplementary Insurance Information — (continued) Years Ended December 31, 2024, 2023 and 2022 (In millions)
|  | Premiums and Universal Life and Investment-Type Product Policy Fees |  | Net Investment Income |  | Policyholder Benefits and Claims, Policyholder Liability Remeasurement (Gains) Losses and Interest Credited to PABs |  | Market Risk Benefit Remeasurement (Gains) Losses |  | Amortization of DAC, VOBA and Negative VOBA Charged to Other Expenses |  | Other Expenses (1)
2024 |  |  |  |  |  |  |  |  |  |  |  |
Group Benefits |  | $ | 23,367 |  |  | $ | 1,178 |  |  | $ | 20,033 |  |  | $ | — |  |  | $ | 26 |  |  | $ | 4,062 |
RIS |  | 8,348 |  |  | 8,291 |  |  | 14,586 |  |  | 11 |  |  | 66 |  |  | 493 |
Asia |  | 6,681 |  |  | 5,099 |  |  | 6,846 |  |  | 7 |  |  | 832 |  |  | 1,600 |
Latin America |  | 5,895 |  |  | 1,608 |  |  | 4,785 |  |  | — |  |  | 503 |  |  | 1,311 |
EMEA |  | 2,516 |  |  | 847 |  |  | 1,797 |  |  | (54) |  |  | 355 |  |  | 891 |
MetLife Holdings |  | 3,106 |  |  | 3,802 |  |  | 4,807 |  |  | (1,074) |  |  | 229 |  |  | 1,461 |
Corporate & Other |  | 6 |  |  | 448 |  |  | 7 |  |  | 1 |  |  | 10 |  |  | 1,773 |
Total |  | $ | 49,919 |  |  | $ | 21,273 |  |  | $ | 52,861 |  |  | $ | (1,109) |  |  | $ | 2,021 |  |  | $ | 11,591 |
2023 |  |  |  |  |  |  |  |  |  |  |  |
Group Benefits |  | $ | 22,436 |  |  | $ | 1,148 |  |  | $ | 19,329 |  |  | $ | — |  |  | $ | 26 |  |  | $ | 3,778 |
RIS |  | 8,561 |  |  | 7,354 |  |  | 14,057 |  |  | (29) |  |  | 49 |  |  | 403 |
Asia |  | 6,883 |  |  | 4,307 |  |  | 6,941 |  |  | (43) |  |  | 772 |  |  | 1,584 |
Latin America |  | 5,685 |  |  | 1,610 |  |  | 4,801 |  |  | — |  |  | 468 |  |  | 1,263 |
EMEA |  | 2,314 |  |  | 885 |  |  | 1,737 |  |  | (40) |  |  | 344 |  |  | 811 |
MetLife Holdings |  | 3,513 |  |  | 4,234 |  |  | 5,517 |  |  | (882) |  |  | 258 |  |  | 1,527 |
Corporate & Other |  | 43 |  |  | 370 |  |  | 23 |  |  | — |  |  | 9 |  |  | 2,040 |
Total |  | $ | 49,435 |  |  | $ | 19,908 |  |  | $ | 52,405 |  |  | $ | (994) |  |  | $ | 1,926 |  |  | $ | 11,406 |
2022 |  |  |  |  |  |  |  |  |  |  |  |
Group Benefits |  | $ | 21,906 |  |  | $ | 1,081 |  |  | $ | 19,226 |  |  | $ | — |  |  | $ | 26 |  |  | $ | 3,460 |
RIS |  | 13,923 |  |  | 5,899 |  |  | 18,124 |  |  | (314) |  |  | 40 |  |  | 380 |
Asia |  | 7,256 |  |  | 3,571 |  |  | 6,199 |  |  | (90) |  |  | 721 |  |  | 1,625 |
Latin America |  | 4,399 |  |  | 1,318 |  |  | 4,092 |  |  | — |  |  | 410 |  |  | 1,032 |
EMEA |  | 2,298 |  |  | (864) |  |  | 30 |  |  | (126) |  |  | 326 |  |  | 783 |
MetLife Holdings |  | 3,968 |  |  | 4,633 |  |  | 5,849 |  |  | (3,144) |  |  | 270 |  |  | 1,632 |
Corporate & Other |  | (15) |  |  | 278 |  |  | (5) |  |  | — |  |  | 9 |  |  | 1,851 |
Total |  | $ | 53,735 |  |  | $ | 15,916 |  |  | $ | 53,515 |  |  | $ | (3,674) |  |  | $ | 1,802 |  |  | $ | 10,763 |
______________ (1)Includes other expenses and policyholder dividends, excluding amortization of DAC, VOBA and negative VOBA charged to other expenses.

X
- References No definition available. + Details
Name: | srt_SupplementaryInsuranceInformationAbstract
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplementary insurance information by segment. Includes, but is not limited to, deferred policy acquisition cost; future policy benefit, loss, claim and loss expenses; unearned premium; other policy claim and benefit payable; premium revenue; net investment income; benefit, claim, loss and settlement expenses; amortization of deferred policy acquisition cost; other operating expense; and premium written. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 16 -Paragraph Column J -Footnote 3 -Publisher SEC Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 16 -Paragraph Column G -Footnote 3 -Publisher SEC Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-16(Column G)(Footnote 3)) -SubTopic 235 -Topic 944 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477965/944-235-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-16(Column J)(Footnote 3)) -SubTopic 235 -Topic 944 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477965/944-235-S99-1 + Details
Name: | srt_SupplementaryInsuranceInformationForInsuranceCompaniesDisclosureTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration